BioCentury
ARTICLE | Product Development

COVID-19 roundup: Lilly joins NIH’s adaptive trial; plus Foresee, Congress, ASCO, BMS, Otsuka, EC, Terumo-Marker

BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.

April 11, 2020 1:29 AM GMT
Updated on Apr 11, 2020 at 1:50 AM GMT
Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

Next in Daily Edition for April 10, 2020